Osteoprotegerin is associated with markers of atherosclerosis in type 2 diabetes patients

被引：0
|
作者：
Idzior-Walus, B. [1 ]
Walus-Miarka, M. [1 ]
Katra, B. [1 ]
Fedak, D. [2 ]
Czarnecka, D. [3 ]
Malecki, M. T. [1 ]
机构：
[1] Jagiellonian Univ, Dept Metab Dis, Krakow, Poland
[2] Jagiellonian Univ, Dept Clin Biochem, Krakow, Poland
[3] Jagiellonian Univ, Dept Cardiol, Krakow, Poland
来源：
DIABETOLOGIA | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1353
引用
收藏
页码：S521 / S521
页数：1
相关论文
共 50 条
  • [11] MARKERS OF ATHEROSCLEROSIS AND ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS
    Starostina, Ekaterina
    Kotovskaya, Yulia
    Kobalava, Zhanna
    JOURNAL OF HYPERTENSION, 2016, 34 : E110 - E110
  • [12] Inflammation and oxidative stress markers in type 2 diabetes patients with Advanced Carotid atherosclerosis
    Menegaut, Louise
    Laubriet, Aline
    Crespy, Valentin
    Leleu, Damien
    Pilot, Thomas
    Van Dongen, Kevin
    de Barros, Jean-Paul Pais
    Gautier, Thomas
    Petit, Jean-Michel
    Thomas, Charles
    Nguyen, Maxime
    Steinmetz, Eric
    Masson, David
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [13] Immunosuppressive markers of atherosclerosis in patients with impaired glucose tolerance and type 2 diabetes mellitus
    Chugunova, L. A.
    Galitsina, N. A.
    Sukhareva, O. Y.
    Knyazeva, A. P.
    Shestakova, M. V.
    DIABETES MELLITUS, 2005, 8 (02): : 54 - 58
  • [14] Visfatin (Nampt) and Ghrelin as Novel Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes
    Kadoglou, N. P. E.
    Sailer, N.
    Moumtzouoglou, A.
    Kapelouzou, A.
    Tsanikidis, H.
    Vitta, I.
    Karkos, C.
    Karayannacos, E.
    Gerasimidis, T.
    Liapis, C. D.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (02) : 75 - 80
  • [15] Osteoprotegerin Is Related to Arterial Stiffness in Patients with Type 2 Diabetes
    Eleftheriadou, Ioanna
    Grigoropoulou, Pinelopi
    Mourouzis, Iordanis
    Kokkinos, Alexander
    Perrea, Despoina
    Katsilambros, Nicholas
    Makrilakis, Konstantinos
    Tentolouris, Nicholas
    DIABETES, 2014, 63 : A112 - A112
  • [16] Osteoprotegerin Is Associated with Cardiovascular Autonomic Nerve Function in Type 2 Diabetes
    Maser, Raelene E.
    Lenhard, M. James
    DIABETES, 2014, 63 : A146 - A146
  • [17] Visceral Adiposity Is Associated with Carotid Atherosclerosis in Male Patients with Type 2 Diabetes
    Morigami, Hirokazu
    Morioka, Tomoaki
    Yamazaki, Yuko
    Imamura, Satoshi
    Numaguchi, Ryutaro
    Asada, Mariko
    Motoyama, Koka
    Mori, Katsuhito
    Fukumoto, Shinya
    Shoji, Tetsuo
    Emoto, Masanori
    Inaba, Masaaki
    DIABETES, 2015, 64 : A729 - A730
  • [18] Hyperresistinemia is associated with high blood pressure and atherosclerosis in patients with type 2 diabetes
    Takata, Yasunori
    Kurata, Mie
    Yamauchi, Junko
    Ochi, Masaaki
    Kawamura, Ryuichi
    Nishida, Wataru
    Fukuoka, Tomikazu
    Onuma, Hiroshi
    Okura, Takafumi
    Higaki, Jitsuo
    Osawa, Haruhiko
    Makino, Hideichi
    HYPERTENSION, 2007, 50 (04) : E134 - E134
  • [19] Low muscle mass is associated with carotid atherosclerosis in patients with type 2 diabetes
    Seo, Da Hea
    Lee, Yong-ho
    Suh, Young Ju
    Ahn, Seong Hee
    Hong, Seongbin
    Choi, Young Ju
    Huh, Byoung Wook
    Park, Seok Won
    Lee, Eunjig
    Kim, So Hun
    ATHEROSCLEROSIS, 2020, 305 : 19 - 25
  • [20] Interrelationship between circulating osteoprotegerin and subclinical coronary atherosclerosis in patients with type two diabetes mellitus
    Berezin, A.
    Kremzer, A.
    CARDIOVASCULAR RESEARCH, 2014, 103
12345